334970 — Prestige Biologics Co Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩246bn
- KR₩334bn
- KR₩13bn
Annual cashflow statement for Prestige Biologics Co, fiscal year end - June 30th, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 6 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -39,378 | -49,718 | -17,980 | -29,374 | -27,469 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 32,453 | 19,835 | 11,157 | -9,771 | -2,764 |
| Unusual Items | |||||
| Purchased R&D | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -22,865 | -12,245 | -1,870 | 19,569 | -1,176 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -25,869 | -34,190 | -4,450 | -8,345 | -18,327 |
| Capital Expenditures | -98,011 | -84,790 | -19,495 | -8,637 | -5,656 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 101 | 1,124 | 18.2 | 711 | 97.7 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -97,910 | -83,665 | -19,477 | -7,927 | -5,558 |
| Financing Cash Flow Items | -28.4 | -42.7 | — | -52.3 | -51.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 156,312 | 96,463 | 53,979 | 345 | -4,041 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 32,533 | -21,392 | 30,052 | -15,928 | -27,926 |